We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.

The full article is available here as HTML.

Press Ctrl-C to copy

Old-fashioned 'parachute science' — in which scientists from industrialised countries fly in to developing countries, obtain blood from a few patients and immediately return home with their samples — is no longer acceptable, say Frances Gotch and Jill Gilmour in Nature Immunology.

Developing country scientists want to take ownership of scientific endeavours, or at least be equal partners, say the authors.

Gotch and Gilmore have helped expand laboratories in Uganda to enable large-scale, international HIV vaccine trials to take place. They say trials must be carried out where the epidemic is worst and that their experience has shown high quality trials and good clinical practice, including sophisticated testing, can be done even in areas where resources are scarce.

Successful laboratory development requires a central 'supporting' laboratory as well as substantial investment in the training of laboratory and managerial staff, and sustained long-term support, they say.

The authors emphasise that publication in reputable journals of exciting and important research by adequately funded, highly qualified scientists in the developing world is of "paramount importance" and might halt the brain drain from the developing world.

Link to full article in Nature Immunology